145 related articles for article (PubMed ID: 37276931)
41. Suspicion of fenofibrate-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report.
Safrano L; Bourneau-Martin D; Le Clech C; Chennebault JM; Jamet A; Drablier G; Lagarce L; Lainé-Cessac P
Therapie; 2014; 69(5):461-4. PubMed ID: 25269143
[TBL] [Abstract][Full Text] [Related]
42. Laryngeal edema in drug reaction with eosinophilia and systemic symptoms syndrome due to sulfasalazine.
Shimada Y; Suyama Y; Koizumi M; Hagiwara K
Int J Rheum Dis; 2023 Nov; 26(11):2317-2319. PubMed ID: 37317785
[TBL] [Abstract][Full Text] [Related]
43. Allopurinol-Induced Drug Reaction With Eosinophilia and Systemic Symptoms: A Case Report.
Myers CM; Miller JJ; Davis WD
Adv Emerg Nurs J; 2020; 42(2):108-118. PubMed ID: 32358426
[TBL] [Abstract][Full Text] [Related]
44. Histopathologic spectrum of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): a diagnosis that needs clinico-pathological correlation.
Borroni G; Torti S; Pezzini C; Vassallo C; Rosso R; D'Ospina RM; Tomasini C; Brazzelli V
G Ital Dermatol Venereol; 2014 Jun; 149(3):291-300. PubMed ID: 24819756
[TBL] [Abstract][Full Text] [Related]
45. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.
Hiransuthikul A; Rattananupong T; Klaewsongkram J; Rerknimitr P; Pongprutthipan M; Ruxrungtham K
Allergol Int; 2016 Oct; 65(4):432-438. PubMed ID: 27134114
[TBL] [Abstract][Full Text] [Related]
46. Drug reaction with eosinophilia and systemic symptoms (DRESS): A tertiary care centre retrospective study.
Del Pozzo-Magaña BR; Rieder MJ; Garcia-Bournissen F; Lazo-Langner A
Br J Clin Pharmacol; 2022 Sep; 88(9):4134-4141. PubMed ID: 35421262
[TBL] [Abstract][Full Text] [Related]
47. Drug reaction with eosinophilia and systemic symptoms syndrome.
Spriet S; Banks TA
Allergy Asthma Proc; 2015; 36(6):501-5. PubMed ID: 26534757
[TBL] [Abstract][Full Text] [Related]
48. Serum Soluble OX40 as a Diagnostic and Prognostic Biomarker for Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.
Mitsui Y; Shinkuma S; Nakamura-Nishimura Y; Ommori R; Ogawa K; Miyagawa F; Mori Y; Tohyama M; Asada H
J Allergy Clin Immunol Pract; 2022 Feb; 10(2):558-565.e4. PubMed ID: 34757063
[TBL] [Abstract][Full Text] [Related]
49. Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature, with a focus on relapsing cases.
Afiouni R; Zeinaty P; Kechichian E; Zoghaib S; Matar S; Helou-Mallat J; Tomb R
Pediatr Dermatol; 2021 Jan; 38(1):125-131. PubMed ID: 33155729
[TBL] [Abstract][Full Text] [Related]
50. DRESS syndrome: an important differential for eosinophilia with systemic organ dysfunction.
Mukit W; Cooper R; Moudgil H; Ahmad N
BMJ Case Rep; 2020 May; 13(5):. PubMed ID: 32398248
[TBL] [Abstract][Full Text] [Related]
51. Acute hepatic failure in trimethoprim-induced drug rash with eosinophilia and systemic symptoms (DRESS).
Connolly A; Walsh S; Philippidou M; Salisbury J; Creamer D
Br J Dermatol; 2023 Jul; 189(1):140-141. PubMed ID: 36946217
[No Abstract] [Full Text] [Related]
52. Drug Reaction With Eosinophilia and Systemic Symptoms.
Krantz MS; Phillips EJ
JAMA Dermatol; 2023 Mar; 159(3):348. PubMed ID: 36630118
[TBL] [Abstract][Full Text] [Related]
53. Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review.
Sharifzadeh S; Mohammadpour AH; Tavanaee A; Elyasi S
Eur J Clin Pharmacol; 2021 Mar; 77(3):275-289. PubMed ID: 33025080
[TBL] [Abstract][Full Text] [Related]
54. Monocytes are involved in the balance between regulatory T cells and Th17 cells in severe drug eruptions.
Ushigome Y; Mizukawa Y; Kimishima M; Yamazaki Y; Takahashi R; Kano Y; Shiohara T
Clin Exp Allergy; 2018 Nov; 48(11):1453-1463. PubMed ID: 30112775
[TBL] [Abstract][Full Text] [Related]
55. Hair loss after drug reaction with eosinophilia and systemic symptoms (DRESS): A multicentric retrospective case series.
Lee JW; Yu DA; Cho S; Youn SW; Kwon O
J Dermatol; 2023 Jun; 50(6):814-819. PubMed ID: 36651019
[TBL] [Abstract][Full Text] [Related]
56. DRESS syndrome: More than just a rash.
Beck J
JAAPA; 2024 Mar; 37(3):1-4. PubMed ID: 38386937
[TBL] [Abstract][Full Text] [Related]
57. Letter from the Editor: Drug reaction with eosinophilia and systemic symptoms syndrome.
Elston DM
J Am Acad Dermatol; 2024 Jun; 90(6):1153-1154. PubMed ID: 37276932
[No Abstract] [Full Text] [Related]
58. Severe enterocolitis associated with antiepileptic-induced drug reaction with eosinophilia and systemic symptoms.
Swanson EA; Low L; Naini BV
Hum Pathol; 2014 Sep; 45(9):1973-7. PubMed ID: 24935058
[TBL] [Abstract][Full Text] [Related]
59. DRESS syndrome: a detailed insight.
Behera SK; Das S; Xavier AS; Selvarajan S
Hosp Pract (1995); 2018 Aug; 46(3):152-162. PubMed ID: 29519170
[TBL] [Abstract][Full Text] [Related]
60. Severe drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms in a 1-month-old infant with trisomy 21.
Osada A; Arimitsu T; Nakazaki H; Kin T; Kaburagi S; Morita K; Nakajima Y; Kitahara H; Takahashi H; Hida M
J Dermatol; 2021 Oct; 48(10):E496-E497. PubMed ID: 34184289
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
